Sun Life Sciences Private Limited, a active private limited company, was established on 22 July 2002 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KA2002PTC030804. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 26 professional, Its leadership includes Naman Porwal (Whole-Time Director), Deepan Ramesh Porwal (Whole-Time Director), Rameshkumar Porwal (Whole-Time Director). Past directors included Naresh Porwal, Shanti Lal Porwal, Vikas Porwal. It holds no open charges and ₹4.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.15, 3Rd Cross, Rv Shetty Layout Sheshadripuram, Bangalore, Karnataka, 560020.
U24231KA2002PTC030804
030804
22 July 2002
₹1.00 Cr
₹1.00 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Sun Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naman Porwal | Whole-Time Director | 01 Oct 2020 | Current |
| Deepan Ramesh Porwal | Whole-Time Director | 18 Feb 2013 | Current |
| Rameshkumar Porwal | Whole-Time Director | 01 Jun 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
| Pramod Abcsdd | Director | 01 Feb 2020 | Past |
| Pramod Abcsdd | Director | 01 Apr 2020 | Past |
| Pramod Abcsdd | Director | 01 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sun Life Sciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.23% increase. The company also saw a substantial improvement in profitability, with a 149.23% increase in profit. The company's net worth Soared by an impressive increase of 24.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sun Life Sciences had a promoter holding of 79.90% and a public holding of 20.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹41,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Dec 2014 | Hdfc Bank Limited | ₹3.00 Cr | Satisfied |
| 30 Nov 2010 | Ing Vysya Bank Limited | ₹7.50 M | Satisfied |
| 23 Jul 2004 | Unon Bank Of India | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Sun Life Sciences has a workforce of 26 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sun Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sun Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sun Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on A charge registered on 22 Dec 2014 via Charge ID 10579258 with Hdfc Bank Limited was fully satisfied on 17 Nov 2020. was documented.
Progress on Naman Porwal was appointed as a Whole-time director was appointed as a Whole-time director on 01 Oct 2020 & has been associated with this company since 5 years 2 months . was documented.
The activity A charge registered on 30 Nov 2010 via Charge ID 10262679 with Ing Vysya Bank Limited was fully satisfied on 22 Nov 2018. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 22 Dec 2014 with Charge ID 10579258 was modified on 15 May 2017. was documented.
The CIN of Sun Life Sciences Private Limited is U24231KA2002PTC030804.
Sun Life Sciences Private Limited is headquartered at No.15, 3Rd Cross, Rv Shetty Layout Sheshadripuram, Bangalore, Karnataka, 560020.
Sun Life Sciences Private Limited was incorporated on 22 July 2002.
The current directors of Sun Life Sciences Private Limited are
The primary industry of Sun Life Sciences Private Limited is Manufacturing.
Sun Life Sciences Private Limited is unlisted.
The authorized capital of Sun Life Sciences Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Sun Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX